ARPA-H’s new FRONT program funds regenerative brain tissue therapies to reverse “permanent” damage from stroke and trauma.


ARPA-H’s new FRONT program funds regenerative brain tissue therapies to reverse “permanent” damage from stroke and trauma.

📢 Submit proposals for ARPA-H SBIR by July 26, 2024, to drive health innovation. Don’t miss the informational session on July 2. 🚀💡